D.A. Davidson & Co. Ionis Pharmaceuticals Inc Transaction History

D.A. Davidson & Co.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$62.09 - $86.14 $2.99 Million - $4.15 Million	-48,172 Closed	0 $0
Q1 2019 May 13, 2019	SELL	$52.92 - $81.17 $81,232 - $124,595	-1,535 Reduced 3.09%	48,172 $3.91 Million
Q4 2018 Jan 29, 2019	SELL	$43.37 - $59.54 $30,532 - $41,916	-704 Reduced 1.4%	49,707 $2.69 Million
Q3 2018 Nov 13, 2018	BUY	$42.88 - $53.7 $3,216 - $4,027	75 Added 0.15%	50,411 $2.6 Million
Q2 2018 Aug 02, 2018	SELL	$40.53 - $50.7 $18,197 - $22,764	-449 Reduced 0.88%	50,336 $2.1 Million
Q1 2018 May 04, 2018	BUY	$44.08 - $55.05 $9,962 - $12,441	226 Added 0.45%	50,785 $2.24 Million
Q4 2017 Feb 08, 2018	SELL	$50.3 - $64.39 $18,611 - $23,824	-370 Reduced 0.73%	50,559 $2.54 Million
Q3 2017 Nov 08, 2017	SELL	$45.56 - $59.57 $1,275 - $1,667	-28 Reduced 0.05%	50,929 $2.58 Million
Q2 2017 Aug 11, 2017	BUY	N/A	50,957	50,957 $0

389

125M

2.25M

510K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.64B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

Stay updated on D.A. Davidson & Co. with notifications on news.